ShRNA-mediated knockdown of Bmi-1 inhibit lung adenocarcinoma cell migration and metastasis

Lung Cancer

Volumn 77, Issue 1, 2012, Pages 24-30

  Meng, Xiuxiang ^a,b   Wang, Yifang ^b   Zheng, Xiangyu ^b   Liu, Chunqing ^b   Su, Benli ^b   Nie, Huiling ^c   Zhao, Baoxia ^b   Zhao, Xinyu ^b   Yang, Hong ^a  

^a LIAONING NORMAL UNIVERSITY   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

^c Pathology Department of Dalian Municipal Fifth Hospital   (China)

Author keywords

Bmi 1; Inhibit; Lung adenocarcinoma; Metastasis; Migration; ShRNA

Indexed keywords

BMI1 PROTEIN; PROTEIN KINASE B; SHORT HAIRPIN RNA; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CELL MIGRATION; CLINICAL ARTICLE; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; LUNG ADENOCARCINOMA; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ADENOCARCINOMA; ADULT; AGED; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASM TRANSPLANTATION; NEOPLASTIC CELLS, CIRCULATING; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; REPRESSOR PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84862822127     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2012.02.015     Document Type: Article

References (26)

1. van der Lugt N.M., Domen J., Linders K., et al. Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. Genes Dev 1994, 8:757-769.
2. Becker M., Korn C., Sienerth A.R., et al. Polycomb group protein Bmi1 is required for growth of RAF driven non-small-cell lung cancer. PLoS One 2009, 4(1):e4230.
3. Kim J.H., Yoon S.Y., Jeong S.H., et al. Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer. Breast 2004, 13(5):383-388.
4. Kim J.H., Yoon S.Y., Kim C.N., et al. The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins. Cancer Lett 2004, 203(2):217-224.
5. Song L.B., Zeng M.S., Liao W.T., et al. Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res 2006, 66:6225-6232.
6. Mihic-Probst D., Kuster A., Kilgus S., et al. Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma. Int J Cancer 2007, 121(8):1764-1770.
7. Glinsky G.V., Berezovska O., Glinskii A.B. Microarray analysis identifies a death from cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest 2005, 115(6):1503-1521.
8. Meng X.X., Liu W.H., Liu D.D., et al. Construction of antisense Bmi-1 expression plasmid and its inhibitory effect on K562 cells proliferation. Chin Med J (Engl) 2005, 118(16):1346-1350.
9. Yu Q., Su B., Liu D., et al. Antisense RNA-mediated suppression of Bmi-1 gene expression inhibits the proliferation of lung cancer cell line A549. Oligonucleotides 2007, 17(3):327-335.
10. Jiang Y., Su B., Meng X., et al. Effect of siRNA-mediated silencing of Bmi-1 gene expression on HeLa cells. Cancer Sci. 2010, 101(2):379-386.
11. Song L.B., Li J., Liao W.T., et al. The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J Clin Invest 2009, 119(12):3626-3636.
12. Pore N., Liu S., Haas-Kogan D.A., et al. PTEN mutation and epidermal growth factor receptor activation regulate vascular endothelial growth factor (VEGF) mRNA expression in human glioblastoma cells by transactivating the proximal VEGF promotor. Cancer Res 2003, 63(1):236-241.
13. Anne C., Joan M. Molecular basis of metastasis. N Engl J Med 2008, 359:2814-2823.
14. van Lohuizen M., Verbeek S., Scheijen B., et al. Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging. Cell 1991, 65(5):737-752.
15. Kim J.H., Yoon S.Y., Jeong S.H., et al. overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer. Breast 2004, 13(5):383-388.
16. Kristiina J., Jaana H., Marjut L., et al. Bmi-1, c-myc Snail expression in primary breast cancers and their metastases-elevated Bmi-1 expression in late breast cancer relapses. Virchows Arch 2011, 459(1):31-39.
17. Li D.W., Tang H.M., Fan J.W., et al. Expression level of Bmi-1 oncoprotein is associated with progression and prognosis in colon cancer. J Cancer Res Clin Oncol 2010, 136:997-1006.
18. Guo B.H., Feng Y., Zhang R., et al. Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer. Molecular Cancer 2011, 10(1):10-33.
19. Jordan C.T., Guzman M.L., Noble M. Cancer stem cells. N Engl J Med 2006, 355:1253-1261.
20. Geva E., Jaffe R.B. Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil Steril 2000, 74:429-437.
21. Jiang B.H., Liu L.Z. AKT signalling in regulating angiogenesis. Curr Cancer Drug Targets 2008, 8:19-26.
22. Jiang B.H., Zheng J.Z., Aoki M., et al. Phosphatidylinositol 3-kinase signalling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc Natl Acad Sci USA 2000, 97:1749-1753.
23. Cheng ZY, Liang WT, Yang XY, et al. PTEN's regulation of VEGF and VEGFR1 expression and its clinical significance in myeloid leukemia. Med Oncol [published online: 01.03.11].
24. Ma J.C., Hirozumi S., Nobuo O., et al. PTEN regulate angiogenesis through PI3K/Akt/VEGF signalling pathway in human pancreatic cancer cells. Mol Cell Biochem. 2009, 331:161-171.
25. Westra W.H. Early glandular neoplasia of the lung. Respir Res 2000, 1:163-169.
26. Tang X., Shigematsu H., Bekele B.N., et al. EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients. Cancer Res 2005, 65:7568-7572.